Primatene Mist epinephrine inhalers for asthma are next in line to be reformulated or pulled from the market

Please see updated information from the FDA concerning the phase-out of CFC inhalers

Primatene Mist epinephrine inhalers for asthma are next in line to be reformulated or pulled from the market.

The current form will no longer be sold by the end of 2011. These will be banned along with the other CFC products. You'll likely get an HFA version by then.

Some pharmacies have had trouble keeping epinephrine inhalers in stock...due to high demand and manufacturing issues.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote